6MT3 image
Entry Detail
PDB ID:
6MT3
Keywords:
Title:
Crystal Structure of HLA-B*18:01 in complex with NP338 influenza peptide
Biological Source:
PDB Version:
Deposition Date:
2018-10-19
Release Date:
2019-02-13
Method Details:
Experimental Method:
Resolution:
1.21 Å
R-Value Free:
0.21
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:HLA class I histocompatibility antigen, B-18 alpha chain
Chain IDs:A
Chain Length:276
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:NP338 peptide
Chain IDs:B
Chain Length:9
Number of Molecules:1
Biological Source:unidentified influenza virus
Polymer Type:polypeptide(L)
Description:Beta-2-microglobulin
Chain IDs:C
Chain Length:100
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Broad CD8+T cell cross-recognition of distinct influenza A strains in humans.
Nat Commun 9 5427 5427 (2018)
PMID: 30575715 DOI: 10.1038/s41467-018-07815-5

Abstact

Newly-emerged and vaccine-mismatched influenza A viruses (IAVs) result in a rapid global spread of the virus due to minimal antibody-mediated immunity. In that case, established CD8+ T-cells can reduce disease severity. However, as mutations occur sporadically within immunogenic IAV-derived T-cell peptides, understanding of T-cell receptor (TCRαβ) cross-reactivity towards IAV variants is needed for a vaccine design. Here, we investigate TCRαβ cross-strain recognition across IAV variants within two immunodominant human IAV-specific CD8+ T-cell epitopes, HLA-B*37:01-restricted NP338-346 (B37-NP338) and HLA-A*01:01-restricted NP44-52 (A1-NP44). We find high abundance of cross-reactive TCRαβ clonotypes recognizing distinct IAV variants. Structures of the wild-type and variant peptides revealed preserved conformation of the bound peptides. Structures of a cross-reactive TCR-HLA-B37-NP338 complex suggest that the conserved conformation of the variants underpins TCR cross-reactivity. Overall, cross-reactive CD8+ T-cell responses, underpinned by conserved epitope structure, facilitates recognition of distinct IAV variants, thus CD8+ T-cell-targeted vaccines could provide protection across different IAV strains.

Legend

Protein

Chemical

Disease

Primary Citation of related structures